Following the recent publication of clinical trial data showing Ivermectin solution to be a safe and effective pediculicide, two further recent items of note:
Firstly, correspondence relating to the parameters of the study and recommendations for treatment in schools, via the New England Journal of Medicine.
Secondly, a study by Hazan et al outlining the pharmacokinetics and safety of 0.5% Ivermectin solution on young children, published in the November 2012 edition of Pediatric Dermatology.